Brief: Sprint Bioscience Q1 Operating Loss Narrows To SEK 3.7 Mln
May 8 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q1 NET SALES SEK 17.9 MILLION VERSUS SEK 0 MILLION YEAR
AGO
* Q1 OPERATING LOSS SEK 3.7 MILLION VERSUS LOSS SEK 12.3
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN3qgjFd
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program